Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (54)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kilkkinen, A.
Right arrow Articles by Adlercreutz, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kilkkinen, A.
Right arrow Articles by Adlercreutz, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 155, No. 5 : 472-477
Copyright © 2002 by The Johns Hopkins University School of Hygiene and Public Health


ORIGINAL CONTRIBUTIONS

Use of Oral Antimicrobials Decreases Serum Enterolactone Concentration

Annamari Kilkkinen1, Pirjo Pietinen1, Timo Klaukka2, Jarmo Virtamo1, Pasi Korhonen1 and Herman Adlercreutz3,4

1 Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki, Finland.
2 Research and Development Unit, Social Insurance Institution, Helsinki, Finland.
3 Institute for Preventive Medicine, Nutrition and Cancer, Folkhälsan Research Center, Helsinki, Finland.
4 Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland.

The lignan enterolactone, a phytoestrogen, may protect against hormone-dependent cancers and cardiovascular diseases. It is produced by the intestinal microflora from dietary precursors. Because of the pronounced impact of antimicrobials on the intestinal microflora, the authors examined whether serum enterolactone concentration is affected by previous use of oral antimicrobials. Enterolactone was measured by time-resolved fluoroimmunoassay in 2,753 Finnish men and women aged 25–64 years who participated in a cross-sectional national survey in 1997. Background information was collected by self-administered questionnaire, and data on antimicrobial treatment were gathered from the nationwide prescription database of the Social Insurance Institution. Serum enterolactone concentration was significantly lower in those who had used oral antimicrobials up to 12–16 months before serum sampling than in nonusers (16.4 vs. 19.3 nmol/liter). The concentration was associated with the number of treatments and the time from the last treatment. Modest differences were present between various antimicrobials. The authors' findings support the crucial role of gut microflora in the metabolism of lignans. Furthermore, recent use of antimicrobials should be considered when the association between serum enterolactone concentration and risk of chronic diseases is studied.

antibiotics; bacteria; biological markers; cross-sectional studies; drug therapy; intestines; lignans; metabolism

Abbreviations: BMI, body mass index; CI, confidence interval; SD, standard deviation; TR-FIA, time-resolved fluoroimmunoassay


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. Sonestedt, S. Borgquist, U. Ericson, B. Gullberg, H. Olsson, H. Adlercreutz, G. Landberg, and E. Wirfalt
Enterolactone Is Differently Associated with Estrogen Receptor {beta}-Negative and -Positive Breast Cancer in a Swedish Nested Case-Control Study
Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3241 - 3251.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Hedelin, M. Lof, M. Olsson, H. Adlercreutz, S. Sandin, and E. Weiderpass
Dietary Phytoestrogens Are Not Associated with Risk of Overall Breast Cancer But Diets Rich in Coumestrol Are Inversely Associated with Risk of Estrogen Receptor and Progesterone Receptor Negative Breast Tumors in Swedish Women
J. Nutr., May 1, 2008; 138(5): 938 - 945.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. Kuijsten, P. C. H. Hollman, H. C. Boshuizen, M. N. C. P. Buijsman, P. van 't Veer, F. J. Kok, I. C. W. Arts, and H. B. Bueno-de-Mesquita
Plasma Enterolignan Concentrations and Colorectal Cancer Risk in a Nested Case-Control Study
Am. J. Epidemiol., March 15, 2008; 167(6): 734 - 742.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
I. E. J. Milder, A. Kuijsten, I. C. W. Arts, E. J. M. Feskens, E. Kampman, P. C. H. Hollman, and P. Van 't Veer
Relation between Plasma Enterodiol and Enterolactone and Dietary Intake of Lignans in a Dutch Endoscopy-Based Population
J. Nutr., May 1, 2007; 137(5): 1266 - 1271.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
M. R. French, L. U. Thompson, and G. A. Hawker
Validation of a Phytoestrogen Food Frequency Questionnaire with Urinary Concentrations of Isoflavones and Lignan Metabolites in Premenopausal Women
J. Am. Coll. Nutr., February 1, 2007; 26(1): 76 - 82.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Rossini, C. Rumio, L. Sfondrini, E. Tagliabue, D. Morelli, R. Miceli, L. Mariani, M. Palazzo, S. Menard, and A. Balsari
Influence of Antibiotic Treatment on Breast Carcinoma Development in Proto-neu Transgenic Mice.
Cancer Res., June 15, 2006; 66(12): 6219 - 6224.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Kuijsten, I. C.W. Arts, P. C.H. Hollman, P. van't Veer, and E. Kampman
Plasma enterolignans are associated with lower colorectal adenoma risk.
Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1132 - 1136.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. Piller, E. Verla-Tebit, S. Wang-Gohrke, J. Linseisen, and J. Chang-Claude
CYP17 Genotype Modifies the Association between Lignan Supply and Premenopausal Breast Cancer Risk in Humans
J. Nutr., June 1, 2006; 136(6): 1596 - 1603.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. Kilkkinen, I. Erlund, M. J. Virtanen, G. Alfthan, K. Ariniemi, and J. Virtamo
Serum Enterolactone Concentration and the Risk of Coronary Heart Disease in a Case-Cohort Study of Finnish Male Smokers
Am. J. Epidemiol., April 15, 2006; 163(8): 687 - 693.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Stuedal, I. T. Gram, Y. Bremnes, H. Adlercreutz, M. B. Veierod, and G. Ursin
Plasma Levels of Enterolactone and Percentage Mammographic Density among Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2154 - 2159.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. Kuijsten, I. C. W. Arts, T. B. Vree, and P. C. H. Hollman
Pharmacokinetics of Enterolignans in Healthy Men and Women Consuming a Single Dose of Secoisolariciresinol Diglucoside
J. Nutr., April 1, 2005; 135(4): 795 - 801.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. Bhakta, I. dos Santos Silva, C. Higgins, L. Sevak, T. Kassam-Khamis, P. Mangtani, H. Adlercreutz, and A. McMichael
A Semiquantitative Food Frequency Questionnaire Is a Valid Indicator of the Usual Intake of Phytoestrogens by South Asian Women in the UK Relative to Multiple 24-h Dietary Recalls and Multiple Plasma Samples
J. Nutr., January 1, 2005; 135(1): 116 - 123.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Olsen, K. E. B. Knudsen, B. L. Thomsen, S. Loft, C. Stripp, K. Overvad, S. Moller, and A. Tjonneland
Plasma Enterolactone and Breast Cancer Incidence by Estrogen Receptor Status
Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2084 - 2089.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. M. Velicer, S. R. Heckbert, J. W. Lampe, J. D. Potter, C. A. Robertson, and S. H. Taplin
Antibiotic Use in Relation to the Risk of Breast Cancer
JAMA, February 18, 2004; 291(7): 827 - 835.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. B. Ness and J. A. Cauley
Antibiotics and Breast Cancer--What's the Meaning of This?
JAMA, February 18, 2004; 291(7): 880 - 881.
[Full Text] [PDF]


Home page
J. Nutr.Home page
A. N. Begum, C. Nicolle, I. Mila, C. Lapierre, K. Nagano, K. Fukushima, S.-M. Heinonen, H. Adlercreutz, C. Remesy, and A. Scalbert
Dietary Lignins Are Precursors of Mammalian Lignans in Rats
J. Nutr., January 1, 2004; 134(1): 120 - 127.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Kilkkinen, J. Virtamo, M. J. Virtanen, H. Adlercreutz, D. Albanes, and P. Pietinen
Serum Enterolactone Concentration Is Not Associated with Prostate Cancer Risk in a Nested Case-Control Study
Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1209 - 1212.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
R. M. Blair, S. E. Appt, A. A. Franke, and T. B. Clarkson
Treatment with Antibiotics Reduces Plasma Equol Concentration in Cynomolgus Monkeys (Macaca fascicularis)
J. Nutr., July 1, 2003; 133(7): 2262 - 2267.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. Kilkkinen, L. M. Valsta, J. Virtamo, K. Stumpf, H. Adlercreutz, and P. Pietinen
Intake of Lignans Is Associated with Serum Enterolactone Concentration in Finnish Men and Women
J. Nutr., June 1, 2003; 133(6): 1830 - 1833.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Vanharanta, S. Voutilainen, T. H. Rissanen, H. Adlercreutz, and J. T. Salonen
Risk of Cardiovascular Disease-Related and All-Cause Death According to Serum Concentrations of Enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study
Arch Intern Med, May 12, 2003; 163(9): 1099 - 1104.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. E. Bach Knudsen, A. Serena, A. K. B. Kjaer, I. Tetens, S.-M. Heinonen, T. Nurmi, and H. Adlercreutz
Rye Bread in the Diet of Pigs Enhances the Formation of Enterolactone and Increases Its Levels in Plasma, Urine and Feces
J. Nutr., May 1, 2003; 133(5): 1368 - 1375.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K. Stumpf and H. Adlercreutz
Short-Term Variations in Enterolactone in Serum, 24-Hour Urine, and Spot Urine and Relationship with Enterolactone Concentrations
Clin. Chem., January 1, 2003; 49(1): 178 - 181.
[Full Text] [PDF]


Home page
NEJMHome page
P. Huovinen
Macrolide-Resistant Group A Streptococcus -- Now in the United States
N. Engl. J. Med., April 18, 2002; 346(16): 1243 - 1245.
[Full Text] [PDF]


Home page
JWatch Infect. DiseasesHome page
Enterolactones, Intestinal Microflora, and Antibiotics
Journal Watch Infectious Diseases, April 11, 2002; 2002(411): 10 - 10.
[Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.